Prostate Cancer - Results from #23520

Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk? - Abstract April 3, 2013

Targeted radiosensitization in prostate cancer - Abstract April 3, 2013

Erectile dysfunction following retropubic prostatectomy - Abstract April 3, 2013

Association between prostate cancer and urinary calculi: A population-based study - Abstract April 3, 2013

The economics of active surveillance for prostate cancer - Abstract April 3, 2013

Chesapeake Urology Associates launches prostate cancer website April 3, 2013

The current role and limitations of surrogate endpoints in advanced prostate cancer - Abstract April 2, 2013

Seminal vesicle invasion in prostate cancer: Evaluation by using multiparametric endorectal MR imaging - Abstract April 2, 2013

A randomised controlled trial of a mindfulness intervention for men with advanced prostate cancer - Abstract April 2, 2013

The association between overall survival of prostate cancer patients and hypertension, hyperglycemia, and overweight in Southern China: A prospective cohort study - Abstract April 2, 2013

Impact of pre-treatment prostate tissue androgen content on the prediction of future castration-resistant prostate cancer development in patients treated with primary androgen deprivation therapy - Abstract April 2, 2013

Impact of inter- and intrafraction deviations and residual set-up errors on PTV margins: Different alignment techniques in 3D conformal prostate cancer radiotherapy - Abstract April 2, 2013

Sexual quality of life in women partnered with men using intracavernous alprostadil injections after radical prostatectomy - Abstract April 2, 2013

Safe digital isolation of the Santorini plexus during radical retropubic prostatectomy - Abstract April 2, 2013

Phase II trial of bevacizumab and satraplatin in docetaxel-pretreated metastatic castrate-resistant prostate cancer - Abstract April 1, 2013

Does positive family history of prostate cancer increase the risk of prostate cancer on initial prostate biopsy? - Abstract April 1, 2013

A randomized, double-blind, placebo-controlled, Phase II study with and without enzastaurin in combination with docetaxel-based chemotherapy in patients with castration-resistant metastatic prostate cancer - Abstract April 1, 2013

Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer - Abstract April 1, 2013

Diagnostic imaging of the prostate cancer - Abstract April 1, 2013

Bone metabolism, renal function and immune structure in prostate cancer. Our experience - Abstract April 1, 2013

Page 1177 of 1436